LIVINGSTON, N.J., Jan. 3 /PRNewswire-FirstCall/ -- Milestone Scientific, Inc. , the recognized leader in advanced injection technologies used by medical and dental professionals worldwide, today announced that it has engaged Elite Financial Communications Group, LLC, a fully integrated financial communications firm, to manage all aspects of its investor and media relations programs.
Commenting on Elite’s appointment, Leonard Osser, Chairman and CEO of Milestone, noted, “We believe that our overall marketing and communications efforts will be strengthened and enhanced by our new relationship with Elite.”
Working closely with Milestone’s management team, Elite is tasked with developing a comprehensive communications platform that will most pro-actively leverage senior management’s strategic vision and industry expertise, and provide meaningful insight into the Company’s operational and financial performance, growth strategy and long term value proposition. In addition, Elite will assist in the development of customized, high-impact and fully integrated media communications programs designed to increase consumer, industry and investor awareness of the Company’s award-winning computer-controlled infusion devices.
Dodi Handy, President and CEO of Elite, added, “With customers spanning 25 countries worldwide, Milestone Scientific has achieved measurable success in its past efforts to pioneer advanced medical and dental devices capable of improving and enhancing the quality of patient care. However, given Milestone’s near term strategy to launch new products and applications centered on its patented injection technologies, the coming year promises to be one defined by potentially remarkable growth opportunities. As such, Elite looks forward to ensuring that due attention is focused on Milestone as they progress their compelling business plan.”
About Elite Financial Communications Group, LLC
Headquartered in Lake Mary, Florida, Elite Financial Communications Group combines diverse expertise, influence, talent and capabilities to achieve quantifiable results for both publicly traded and privately held companies. For more information on Elite, please visit www.efcg.net.
About Milestone Scientific, Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific, Inc. has developed and currently manufactures, markets and sells a proprietary, patented computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in Dentistry under the trademark “CompuDent” and in Medicine under the trademark “CompuMed.” CompuDent(TM) is suitable for all dental procedures, while CompuMed(TM) is suitable for many medical procedures regularly used in Plastic Surgery, Hair Restoration Surgery, Podiatry, Colorectal Surgery, Dermatology, Orthopedics, and a number of other disciplines. CompuDent and CompuMed are sold in the United States and worldwide in over 25 countries. Both systems comprise a microprocessor-controlled drive unit as well as The Wand(R) handpiece, a single patient use product that is held in a pen-like manner for injections. The Company also sells the SafetyWand(R), which incorporates engineered sharps injury protection features to aid in the prevention of accidental needle sticks. Milestone has also developed proprietary consumer (Ionic White(TM)) and professional (CoolBlue(TM)) teeth whitening systems.
Safe Harbor Statement: This press release contains forward-looking statements regarding the timing and financial impact of the Milestone’s ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report on Form 10-KSB for the year ended December 31, 2006. The forward looking-statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief Strategist 407-585-1080 or via email at mlss@efcg.net
Milestone Scientific, Inc.
CONTACT: Dodi Handy, President and CEO, or Daniel Conway, ChiefStrategist, both of Elite Financial Communications Group, LLC,+1-407-585-1080, mlss@efcg.net, for Milestone Scientific, Inc.
